| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 |
| filingDate |
2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f6ca3daf0d46fb23a444dfb51afb77a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f231abb39ecfb22871bd3cdfc1b34277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_119f3d87ce6a6a670667cf955bff6d92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b754b9091ced7df0576213d9722c20e5 |
| publicationDate |
2014-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2439802-T3 |
| titleOfInvention |
Tri- or tetra-specific antibodies |
| abstract |
Trispecific or tetra-specific antibody, comprising: a) the light chain and heavy chain of a full-length antibody that specifically binds to a first antigen, and b) the modified light chain and the modified heavy chain of a full-length antibody that specifically binds to a second antigen, in which the variable domains VL and VH are mutually substituted, and / or in which the constant domains CL and CH1 are mutually substituted, and c) wherein one to four antigen-binding peptides that specifically bind to one or two additional antigens are fused through a peptide linker with the C-terminal or N-terminal end of the light chains or heavy chains of a) and / or b). |
| priorityDate |
2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |